title: Use of vasopressors in Takotsubo cardiomyopathy: a cautionary tale.
authors: M
authors: M
authors: Redmond
authors: C
authors: C
authors: Knapp
authors: M
authors: M
authors: Salim
authors: S
authors: S
authors: Shanbhag
authors: R
authors: R
authors: Jaumdally
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000009:adverse effects / Q000627:therapeutic use; D004381:Duodenal Ulcer / Q000150:complications; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008680:Metaraminol / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications; D010439:Peptic Ulcer Perforation / Q000150:complications; D012769:Shock / Q000150:complications; D054549:Takotsubo Cardiomyopathy / Q000188:drug therapy*; D014662:Vasoconstrictor Agents / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D000316:Adrenergic alpha-Agonists; D014662:Vasoconstrictor Agents; D008680:Metaraminol